1. Home
  2. TNFA vs CNET Comparison

TNFA vs CNET Comparison

Compare TNFA & CNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNFA
  • CNET
  • Stock Information
  • Founded
  • TNFA 2014
  • CNET 2003
  • Country
  • TNFA United States
  • CNET China
  • Employees
  • TNFA N/A
  • CNET N/A
  • Industry
  • TNFA
  • CNET Advertising
  • Sector
  • TNFA
  • CNET Consumer Discretionary
  • Exchange
  • TNFA NYSE
  • CNET Nasdaq
  • Market Cap
  • TNFA 3.2M
  • CNET 3.2M
  • IPO Year
  • TNFA N/A
  • CNET N/A
  • Fundamental
  • Price
  • TNFA $1.16
  • CNET $1.63
  • Analyst Decision
  • TNFA
  • CNET
  • Analyst Count
  • TNFA 0
  • CNET 0
  • Target Price
  • TNFA N/A
  • CNET N/A
  • AVG Volume (30 Days)
  • TNFA 297.1K
  • CNET 30.2K
  • Earning Date
  • TNFA 11-14-2024
  • CNET 11-19-2024
  • Dividend Yield
  • TNFA N/A
  • CNET N/A
  • EPS Growth
  • TNFA N/A
  • CNET N/A
  • EPS
  • TNFA N/A
  • CNET N/A
  • Revenue
  • TNFA N/A
  • CNET $18,458,000.00
  • Revenue This Year
  • TNFA N/A
  • CNET N/A
  • Revenue Next Year
  • TNFA N/A
  • CNET N/A
  • P/E Ratio
  • TNFA N/A
  • CNET N/A
  • Revenue Growth
  • TNFA N/A
  • CNET N/A
  • 52 Week Low
  • TNFA $1.05
  • CNET $1.43
  • 52 Week High
  • TNFA $5.91
  • CNET $4.96
  • Technical
  • Relative Strength Index (RSI)
  • TNFA 44.65
  • CNET 44.19
  • Support Level
  • TNFA $1.12
  • CNET $1.43
  • Resistance Level
  • TNFA $1.52
  • CNET $1.72
  • Average True Range (ATR)
  • TNFA 0.12
  • CNET 0.14
  • MACD
  • TNFA -0.00
  • CNET -0.02
  • Stochastic Oscillator
  • TNFA 12.20
  • CNET 30.30

About TNFA TNF PHARMACEUTICALS INC EFFEC

TNF Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. The company is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. Supera-CBD is a synthetic derivative of CBD being developed to treat various conditions, including epilepsy, pain, and anxiety/depression, through its effects on the CB2 receptor, opioid receptors, and monoamine oxidase enzyme type B.

About CNET ZW Data Action Technologies Inc.

ZW Data Action Technologies Inc is engaged in providing Internet advertising, precision marketing, e-commerce online to offline (O2O) advertising and marketing services as well as the related data and technical services to small and medium enterprises in the PRC. It offers a variety channels of advertising and marketing services through its system, including distribution of the right to use search engine marketing services, provision of online advertising placements on its web portals, provision of ecommerce O2O advertising and marketing services and provision of other related value-added data and technical services to maximize market exposure and effectiveness for clients.

Share on Social Networks: